These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2949654)

  • 21. [Fibrinolytic activity in endometrium and uterine fluid of women using intrauterine contraceptive devices].
    Lu Q
    Shengzhi Yu Biyun; 1983 Aug; 3(3):6-8. PubMed ID: 12267402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrical activity of the human uterus in the presence of intrauterine contraceptive device.
    Serr DM; Mannor SM; Zakut H
    Obstet Gynecol; 1970 Feb; 35(2):217-20. PubMed ID: 5414208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaginal pH effects caused by OCs and various copper and inert IUDs.
    Kandil O; Hassanein MK; El-tagi A; El-shirbini MT
    Contracept Deliv Syst; 1983 Jul; 4(3):187-93. PubMed ID: 12265361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum prolactin levels in lactating women using progestasert system.
    Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MT
    Popul Sci; 1981; (2):115-20. PubMed ID: 12339477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The menstrual cycle and sexual relations in users of the IUD and periodic abstinence].
    Rojas OL
    Acta Med Valle; 1977; 8(1):19-25. PubMed ID: 12229773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The cervix and hormonal contraception].
    Gorins A
    Contracept Fertil Sex (Paris); 1985; 13(7-8):895-9. PubMed ID: 12340276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Morphological changes in the endometrium of women using an intrauterine contraceptive device].
    Grishchenko VI; Iakovtsova AF; Liss NL; Titarenko LE; Ofitserov VN
    Akush Ginekol (Mosk); 1980 Mar; (3):41-2. PubMed ID: 7377499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin levels in the cervical mucus of copper intrauterine contraceptive device users.
    Makhlouf H; Abou-gabal A; El-hefnawi N; Khalifa A
    Popul Sci; 1988; (8):19-29. PubMed ID: 12343623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Menstrual blood loss during oral contraceptive therapy and in IUD users.
    Hefnawi F; Younis N; Zaki K; Rassik SA; Mekkawi T
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):1-4. PubMed ID: 12254505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytological study in cases with intrauterine contraceptive device (Lippes' Loop).
    Aikat M; Pande M
    J Obstet Gynaecol India; 1968 Apr; 18(2):270-3. PubMed ID: 12331818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A possible role of prostaglandin E1 in the mechanism of action of intrauterine contraceptive device.
    Das R; Hrishikeshwan HJ; Bapna JS; Dandiya PC; Ramesh S
    Indian J Med Res; 1977 Mar; 65(3):353-6. PubMed ID: 924547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duration of lactation and return of menstruation in lactating women using hormonal contraception and IUDs.
    Prema K
    Contracept Deliv Syst; 1982 Jan; 3(1):39-46. PubMed ID: 12264126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The circadian pattern of melatonin and its positive relationship with progesterone in women.
    Webley GE; Leidenberger F
    J Clin Endocrinol Metab; 1986 Aug; 63(2):323-8. PubMed ID: 3722324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The acceptability of current contraceptive methods to adolescents].
    Sotnikova EI; Dubnitskaia LV; Perminova SG
    Akush Ginekol (Mosk); 1993; (3):26-30. PubMed ID: 8048682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Contraception and subsequent fertility. Results of a retrospective study].
    Spira N; Spira A; Schwartz D
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):353-8. PubMed ID: 12280206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effect of an intrauterine contraceptive device on genital organs of rhesus monkeys. A 4 and one-half year study.
    Kar AB; Chandra H; Kamboj VP; Chowdhury SR; Roy SK
    Am J Obstet Gynecol; 1970 Feb; 106(3):457-62. PubMed ID: 4983374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal evaluation of the intrauterine progesterone contraceptive system.
    Bryand-Greenwood GD; Greenwood FC; Hale RW; Morishige WK
    J Clin Endocrinol Metab; 1977 Apr; 44(4):721-7. PubMed ID: 849982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Which stage of the menstrual cycle in best suited for the insertion of IUD?].
    Havránek F
    Cesk Gynekol; 1978 Jul; 43(6):447. PubMed ID: 679301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progesterone and estradiol patterns in women using an intrauterine contraceptive device.
    Brenner PF; Mishell DR
    Obstet Gynecol; 1975 Oct; 46(4):456-9. PubMed ID: 1165881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intrauterine contraception in women over 35-years old: comparison between copper and progesterone IUDs].
    Calzolari E; Galoppi P; Masala L; Parisi C; Iannucci D; Salmaggi P; Custo GM; Zichella L
    Patol Clin Ostet Ginecol; 1985; 13(1):49-56. PubMed ID: 12342024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.